Spikevax JN.1

N/A

Report date: 2026/04/17 20:02:02

Base Information

Drug NameSpikevax JN.1

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineCell and gene therapy > Gene therapy > LNPVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsCoronavirus Disease 2019 (COVID-19)

Approved Indications in ChinaN/A

Original Approved Country/TerritoryAustralia

Original Approved Date2026/03/01

Country/TerritoryAustralia

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesModerna Inc

China Registration ClassN/A

Develop Information

Active CompaniesModerna Inc

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A